CHEMOMAB THERAPEUTICS LTD (CMMB)

US16385C1045 - ADR

1.9  -0.08 (-4.04%)

After market: 1.87 -0.03 (-1.58%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-9-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
N/AN/A0.000.000.00
Cost Of Goods
N/A3.36M2.87MN/AN/A
Gross Profit
N/AN/A-2.87MN/AN/A
Operating Expenses
15.37M22.10M25.66M12.37M10.96M
Research and Development
11.97M18.24M13.87M6.33M3.78M
Selling, General, and Administrative Expenses
3.40M7.21M11.80M6.03M7.18M
Operating Income
-15.37M-25.46M-28.53M-12.37M-10.96M
Interest Income/Expense
975.00K1.24M350.00K-110.00K100.00K
Other Income/Expense
N/AN/AN/AN/AN/A
Non Recurring Items
N/AN/AN/AN/A-750.00K
Income Before Taxes
-14.40M-24.22M-28.18M-12.48M-11.61M
Income Tax
0.000.00-530.00KN/AN/A
Net Income
-14.40M-24.22M-27.65M-12.48M-11.61M
EBITDA
N/A-25.39M-28.47M-12.34M-10.94M
 
Per Share Data
EPS Diluted Total Ops
-0.92-1.92-36.07-17.85-93.16
Non GAAP EPS
N/AN/A-1.75-1.18N/A
 
Statistics

All data in USD

Charts